Live tape
Top 8, mentions 7d10,784GOOGL2,064 mentions▲ +0.04SNDK1,523 mentions▲ +0.11SPCX1,495 mentions▲ +0.08NBIS1,421 mentions▲ +0.09HTZ1,232 mentions▲ +0.10NVDA1,190 mentions▲ +0.08META1,018 mentions▲ +0.03MSFT841 mentions▲ +0.06

Equity · Healthcare

TNGX

Tango Therapeutics, Inc. · NasdaqGM

$28.50 +1.79% 1D Finazon · prior-day close · Jul 17, 2026
Price · Chart
Our own end-of-day closes 40 sessions
$35 $15 20 May 17 Jul

The line runs $21.07 on 20 May through $28.50 on 17 July, on a scale from $15 to $35. Days the market did not trade hold the previous close, flat.

The chart above plots the price of TNGX over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 40 sessions over that window: $21.07 on 20 May 2026 through $28.50 on 17 July 2026.

Market cap $4.8B
52-week range $6 – $32.91
Avg volume 1.1M

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 18, 2026

TNGX insider trades

SEC Form 4

TNGX has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 3 November 2025.

Date Insider Type Shares Value
23 Oct 2025 Third Rock Ventures IV, L.P. Sell 477,401 $4.85M
25 Sep 2025 Third Rock Ventures IV, L.P. Sell 500,000 $4.01M
16 Sep 2025 Third Rock Ventures IV, L.P. Sell 363,541 $2.56M
08 Sep 2025 Third Rock Ventures IV, L.P. Sell 86,459 $609K
05 Sep 2025 Third Rock Ventures IV, L.P. Sell 642,906 $4.50M
22 Aug 2025 Third Rock Ventures IV, L.P. Sell 302,194 $2.12M
19 Aug 2025 Third Rock Ventures IV, L.P. Sell 1,100,000 $7.71M

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
03 Nov 2025 Peters Malte Award 150,000

TNGX reported financials

SEC EDGAR XBRL

TNGX reported revenue of $62.4M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$101.6M.

Figure Reported Period
Revenue $62.4M 31 Dec 2025 fiscal year
Net income −$101.6M 31 Dec 2025 fiscal year
Diluted EPS −$0.87 31 Dec 2025 fiscal year
Total assets $1.1B 30 Jun 2026 at period end
Total equity $1.0B 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

TNGX earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $-0.37
31 Mar 2026 Q1 2026 $-0.32
31 Dec 2025 FY 2025 $-0.87 $62M
30 Sep 2025 Q3 2025 $0.13 $54M
30 Jun 2025 Q2 2025 $-0.35 $3M
31 Mar 2025 Q1 2025 $-0.36 $5M
31 Dec 2024 FY 2024 $-1.19 $42M
30 Sep 2024 Q3 2024 $-0.27 $12M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

TNGX institutional holders

SEC Form 13F

10 of the 45 institutional funds we track reported a TNGX position for the quarter ended 30 Jun 2026 — a combined $161.3M; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
Balyasny Asset Management Trimmed −47.3% shares 2,016,379 $63.0M
Renaissance Technologies New position 748,300 $23.4M
Fisher Asset Management Added +256.0% shares 578,158 $18.1M
Millennium Management Held (±25%) +16.5% shares 496,036 $15.5M
Baker Bros. Advisors New position 333,333 $10.4M
Point72 Asset Management Trimmed −44.1% shares 298,339 $9.3M
Two Sigma Investments Added +39.7% shares 241,783 $7.6M
Citadel Advisors Held (±25%) +0.9% shares 181,059 $5.7M
Marshall Wace New position 174,909 $5.5M
AQR Capital Management Held (±25%) −15.2% shares 91,029 $2.8M

Source: SEC EDGAR 13F filings

TNGX fails-to-deliver

SEC CNS data

On 29 Jul 2026, 227,976 shares of TNGX failed to deliver (about $6.1M).

Settlement date Shares failed Notional % of shares out
29 Jul 2026 227,976 $6.1M 0.135%
27 Jul 2026 303 $8K <0.001%
23 Jul 2026 412 $12K <0.001%
16 Jul 2026 149,777 $4.5M 0.089%
09 Jul 2026 915 $28K 0.001%
08 Jul 2026 1,132 $34K 0.001%

Source: SEC fails-to-deliver (CNS) data